ArticleCureus2024
The Ineffectiveness of Osimertinib in Epidermal Growth Factor Receptor (EGFR)-Mutated Stage IV Lung Adenocarcinoma With Bone Metastasis: A Case Report.
Caitlyn H Livingston et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.